Mitchell Sanders, PhD currently is the Chief Scientific Officer of Alira Health and WoundForce LLC, and CEO of FIreFly Innovations LLC. Mitch is a serial entrepreneur and angel investor. In the past 15 years Mitch has secured over $45M in strategic financing and equity investments for new product offerings, mostly in advanced wound care.

Mitch as over 30 years of experience in preclinical animal models and clinical product development in advanced wound care. He has produced over 14 peer-reviewed publications and 40 worldwide patents in medical device and in vitro diagnostics. He is an expert in clinical and translational research and is a reviewer for the Wound Healing Society, Wounds International, Tissue Engineering, CIMIT, MassVentures, MIT, WPI, Tech Sandbox, Piranha Pond, SBANE and the Venture Forum.

Mitch has BS in Biology with a minor in Latin Language and Literature from Boston University, an MS & PhD from WPI in Molecular Biology and biomedical sciences, and Postdoctoral training in (biochemistry and pathogen genetics) at the Whitehead Institute/MIT.

Mitch is an active member of the Wound Healing Society and serves on three committees: Industrial, Communications, and Program.